cafepharma

@cafepharma@toot.community
39 Followers
7 Following
498 Posts
The original site for employees in pharma, medical, and diagnostic sales and related industries. Join us and stay informed.
homepagehttp://www.cafepharma.com
cafepharmaDec 18
Wed news: Pfizer CEO and RFK Jr.. Merck joins obesity pill race. Astellas menopause med gets black box. Sensorion gene therapy for hearing loss. Merck targets 2025 RSV season. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 17
Tue news: Sanofi gets FDA fast track for combo flu/COVID vaccines. Pfizer expects $1B hit in 2025. JNJ blockbuster hopes for Rybrevant dented. Jazz Pharma searching for new CEO. Merck losing TIGIT and LAG-3 cancer drugs. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 16
Mon news: Novo planning Denmark production plant. Study links Ozempic to rare vision loss condition. 3 closely watched drugs that failed in the clinic. Breakthrough status for Sanofi MS drug. Novo Holdings/Catalent deal a go. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 13, 2024
Fri news: AbbVie buying Roche spinout Nimble. UK private market prefers Mounjaro vs Wegovy. ICER finds more ‘unsupported’ drug price hikes. Beigene’s $150M cancer deal. Editas layoffs. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 12, 2024
Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 11, 2024
Wed news: Gilead HIV pipeline. Walgreens may go private. How Trump 2.0 will affect medtech. Lilly to offer Zepbound via Ro Telehealth. Pharma’s regulatory optimism. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 10, 2024
Tue news: BioNTech breast cancer treatment promising. Cardiff Onc drug in colorectal cancer. What’s next for 23andMe? UniQure Huntington’s success. GSK in AI collab. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 9, 2024
Mon news: AstraZeneca BiTE for follicular lymphoma. Mixed data for Keytruda/Lynparza in ovarian cancer. AbbVie’s Parkinson’s prospect. Merck’s ROR1 drug hits lymphoma target. Half of pharma using AI and big data. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 6, 2024
Fri news: FDA outlines accelerated review guidelines. Teva divests its Japan venture. DualityBio/BioNTech ADC data. Learning from 2024 biotech IPOs. Trump’s proposed tariffs and generic drugs. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaDec 5, 2024
Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. —http://bit.ly/w28kSd
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma